Workflow
呼吸系统类药品
icon
Search documents
罗欣药业股价下跌1.49% 股东户数半月激增88%
Jin Rong Jie· 2025-08-06 17:56
Group 1 - The stock price of Luoxin Pharmaceutical is reported at 5.95 yuan as of August 6, 2025, reflecting a decline of 1.49% from the previous trading day [1] - The trading volume on the same day reached 725,895 hands, with a total transaction amount of 435 million yuan, and a price fluctuation of 5.30% [1] - Luoxin Pharmaceutical operates in the chemical pharmaceutical industry, focusing on drug research, production, and sales, with product lines including anti-infection, digestive system, and respiratory system medications [1] Group 2 - The number of shareholders in Luoxin Pharmaceutical significantly increased by 31,700 from July 18 to July 31, 2025, marking a growth rate of 88.04% [1] - As of July 31, 2025, the total number of shareholders reached 67,800, with an average market value of circulating shares held by each shareholder at 104,200 yuan [1] - On August 6, 2025, the net outflow of main funds for Luoxin Pharmaceutical was 26.09 million yuan, with a cumulative net outflow of 22.39 million yuan over the past five days [1]
罗欣药业股价震荡下行 成交额达6.72亿元
Jin Rong Jie· 2025-08-04 20:22
Core Viewpoint - 罗欣药业's stock price experienced a decline on August 4, closing at 6.13 yuan, down 0.22 yuan or 3.46% from the previous trading day [1] Group 1: Stock Performance - On August 4, the stock opened at 6.23 yuan, reached a high of 6.53 yuan, and a low of 6.03 yuan, with a trading volume of 1.0818 million hands and a transaction amount of 672 million yuan [1] - The stock showed rapid fluctuations during the day, with a rebound of over 2% within 5 minutes at 9:36 AM, reaching 6.5 yuan, followed by a decline of over 2% within 5 minutes at 9:43 AM, dropping to 6.26 yuan [1] Group 2: Capital Flow - On August 4, the net inflow of main funds was 13.1726 million yuan, accounting for 0.2% of the circulating market value [1] - Over the past five trading days, the cumulative net inflow of main funds was 25.3391 million yuan, representing 0.38% of the circulating market value [1] Group 3: Company Overview - 罗欣药业 operates in the chemical pharmaceutical industry, focusing on the research, production, and sales of pharmaceutical products [1] - The company's product line includes medications for anti-infection, digestive system, and respiratory system [1]